Geneos Wealth Management Inc. Innoviva, Inc. Transaction History

Geneos Wealth Management Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$14.32 - $19.88 $114 - $159	-8 Reduced 1.13%	700 $10,000
Q1 2022 May 16, 2022	BUY	$15.39 - $20.25 $123 - $162	8 Added 1.14%	708 $13,000
Q4 2020 May 19, 2021	SELL	$9.33 - $12.48 $11,429 - $15,288	-1,225 Reduced 63.64%	700 $8,000
Q3 2019 Sep 07, 2021	SELL	$10.05 - $14.55 $8,542 - $12,367	-850 Reduced 30.63%	1,925 $19,000
Q4 2018 Sep 07, 2021	SELL	$13.96 - $18.26 $4,886 - $6,391	-350 Reduced 11.2%	2,775 $47,000
Q1 2017 Sep 07, 2021	SELL	N/A	-71 Reduced 2.22%	3,125 $43,000
Q4 2016 Sep 07, 2021	SELL	N/A	-1,350 Reduced 29.7%	3,196 $34,000
Q3 2016 Sep 07, 2021	SELL	N/A	-679 Reduced 13.0%	4,546 $49,000
Q1 2016 Sep 07, 2021	BUY	N/A	5,225	5,225 $67,000

228

78.9M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.21B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

Stay updated on Geneos Wealth Management Inc. with notifications on news.